Targeted drug approvals in 2023: breakthroughs by the FDA and NMPA

According to the official website of China's National Medicines and Pharmaceutical Administration(NMPA),a total of 87 novel drugs were approved in China in 2023,with targeted drugs accounting for 67.8％of the total,amounting to 59 drugs(Fig.1a;Table 1)[https:/].